{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:16:52Z","timestamp":1789910212017,"version":"4.0.1"},"reference-count":59,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1080\/17425255.2018.1421173","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T19:26:41Z","timestamp":1513970801000},"page":"219-227","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":21,"title":["Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection"],"prefix":"10.1080","volume":"14","author":[{"given":"Ashly","family":"Maughan","sequence":"first","affiliation":[{"name":"Yale AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onyema","family":"Ogbuagu","sequence":"additional","affiliation":[{"name":"Yale AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i34.7824"},{"key":"CIT0002","first-page":"1","volume":"61","author":"Smith BD","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1007\/s40471-017-0108-x"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.07.006"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis928"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0010.2717"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.01.028"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v9.i21.921"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1126\/science.2523562"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu675"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1311-3"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2016.1132699"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012073432302"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200216030-00006"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010494"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012912"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.03.047"},{"key":"CIT0018","author":"Chahine EB","year":"2016","journal-title":"The Annals of pharmacotherapy"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i26.4759"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.1957.0048"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5421.1835"},{"key":"CIT0022","unstructured":"Roche. PEGASYS\u00ae (peginterferon alfa-2a): drug prescribing information. (Ed.^(Eds) (September 2008)"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2010.08.008"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.14.4.778-809.2001"},{"key":"CIT0025","unstructured":"Lamb M, Marks I, Wynohradnyk L, et al. 40 kDa peginterferon alfa-2a (PEGASYS (R)) can be administered safely in patients with end-stage renal disease. In:Hepatology. (Ed.^(Eds) (WB SAUNDERS CO INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA, 2001) 326A-326A."},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12528"},{"issue":"15","key":"CIT0027","volume":"10","author":"Garcia-Garcia I","year":"2010","journal-title":"BMC Pharmacol"},{"issue":"4","key":"CIT0028","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/135965350400900405","volume":"9","author":"Bruno R","year":"2004","journal-title":"Antivir Ther"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05131.x"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-5-200403020-00010"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014463"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013086"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60494-3"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60538-9"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.02.051"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)71002-3"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307498"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.10.007"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214853"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70033-1"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27567"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280302"},{"key":"CIT0043","unstructured":"Algranati N, Sy S, Modi M. A branched methoxy 40 KDA polyethylene glycol (PEG) moiety optimizes the pharmacokinetics (PK) of peginter-feron alpha-2A (PEG-IFN) and may explain its enhanced efficacy in chronic hepatitis C (CHC). In:Hepatology. (Ed.^(Eds) (WB SAUNDERS CO INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, Philadelphia, PA 19106-3399 USA, 1999) 190A-190A."},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200216020-00004"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012073432301"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30306.x"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020047"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00871.x"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70138-X"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208953"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-016-0110-5"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2013.826136"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-11-201312030-00005"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307080"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2017.03.014"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2016.01.020"},{"key":"CIT0057","first-page":"Cd011644","volume":"3","author":"Kalafateli M","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1086\/655682"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1159\/000437427"}],"container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2018.1421173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T03:01:24Z","timestamp":1660186884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2018.1421173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2,1]]}},"alternative-id":["10.1080\/17425255.2018.1421173"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2018.1421173","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-12-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}